Wrap-Up: Vyvgart Targets Four Populations at AAN 2026
AAN 2026 highlights transformative ADAPT data, expanding Vyvgart across MG subtypes and CIDP, signaling targeted biologics, pediatric advances, and urgent updates to managed care coverage frameworks.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.